Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 16, 2024 06:18 ET | Source: Kronos Advanced Technologies Inc.

Kronos Advanced Technologies Inc. Warns Consumers to Use Only FDA-Cleared Air Purifiers at Home and Office

Los Angeles, CA , July 16, 2024 (GLOBE NEWSWIRE) -- Los Angeles, CA July 16, 2024 (GLOBE NEWSWIRE) -- KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"), an...
July 11, 2024 12:21 ET | Source: Tevogen Bio Inc

Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback

WARREN, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
June 27, 2024 10:30 ET | Source: BioNTech SE

Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron JN.1 angepassten COVID-19-Impfstoff in der Europäischen Union

Der aktualisierte COVID-19-Impfstoff ist auf die Omikron JN.1-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen und...
June 27, 2024 10:30 ET | Source: BioNTech SE

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical and...
June 25, 2024 08:05 ET | Source: Tevogen Bio Inc

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances

WARREN, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
June 14, 2024 14:00 ET | Source: Airfinity

Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels

London, England, June 14, 2024 (GLOBE NEWSWIRE) -- Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels New analysis by Airfinity and...
June 10, 2024 08:55 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will...
May 30, 2024 15:01 ET | Source: MIT Sloan School of Management

Misleading COVID-19 headlines from mainstream sources did more harm on Facebook than fake news

Cambridge, MA, May 30, 2024 (GLOBE NEWSWIRE) -- Since the rollout of the COVID-19 vaccine in 2021, fake news on social media has been widely blamed for low vaccine uptake in the United States — but...
May 23, 2024 08:00 ET | Source: Traws Pharma, Inc.

Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate

Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
May 21, 2024 14:30 ET | Source: InflaRx N.V.

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data...